Rosellini Scientific was a private equity firm that focuses on ideas driven entirely by clinical requirements. It addressed clinical needs with the help of tele-medicine, active implantable devices, drug delivery combinations, interventional devices, nanotechnology and by using novel biomaterials. It was an operational investment company that fosters technology development through collaborations with leading researchers, as well as partnerships with pioneering companies and universities. It focused exclusively on its rapid, highly capital efficient development process and seeks to invest in medical equipment development businesses, hospitals, rehabilitation centers and nursing homes. The firm was headquartered in Dallas, Texas.